The antiproliferative effects of ouabain and everolimus on adrenocortical tumor cells

Endocrine Journal

Volumn 61, Issue 1, 2014, Pages 41-53

  Pezzani, Raffaele ^a   Rubin, Beatrice ^a   Redaelli, Marco ^a   Radu, Claudia ^b   Barollo, Susi ^a   Cicala, Maria Verena ^a   Salvà, Monica ^a   Mian, Caterina ^a   Mucignat Caretta, Carla ^a   Simioni, Paolo ^b   Iacobone, Maurizio ^a   Mantero, Franco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Adrenocortical tumor; Antiproliferative; Everolimus; Ouabain; Primary cell cultures

Indexed keywords

CASPASE; EVEROLIMUS; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; OUABAIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROPIDIUM IODIDE; PROTEIN KINASE B;

ADRENAL CORTEX TUMOR; ADULT; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BIOASSAY; CELL CYCLE REGULATION; CELL DEATH; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MIDDLE AGED; MTT ASSAY; SIGNAL TRANSDUCTION; STAINING; STROPHANTHUS; THYMIDINE INCORPORATION ASSAY; TUMOR CELL; WESTERN BLOTTING; WRIGHT STAINING;

ADRENAL CORTEX NEOPLASMS; ADULT; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; OUABAIN; SIROLIMUS;

EID: 84893392058     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ13-0225     Document Type: Article

References (24)

1. Zhang L, Zhang Z, Guo H, Wang Y (2008) Na+/ K+-ATPase-mediated signal transduction and Na+/K+-ATPase regulation. Fundam Clin Pharmacol 22: 615-621.
2. Ihenetu K, Qazzaz HM, Crespo F, Fernandez-Botran R, Valdes R Jr. (2007) Digoxin-like immunoreactive factors induce apoptosis in human acute T-cell lymphoblastic leukemia. Clin Chem 53: 1315-1322.
3. Qiu J, Gao HQ, Zhou RH, Liang Y, Zhang XH, et al. (2007) Proteomics analysis of the proliferative effect of low-dose ouabain on human endothelial cells. Biol Pharm Bull 30: 247-253.
4. Stenkvist B (1999) Is digitalis a therapy for breast carcinoma? Oncol Rep 6: 493-496.
5. Stenkvist B, Bengtsson E, Dahlqvist B, Eriksson O, Jarkrans T, et al. (1982) Cardiac glycosides and breast cancer, revisited. N Engl J Med 306: 484.
6. McConkey DJ, Lin Y, Nutt LK, Ozel HZ, Newman RA (2000) Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells. Cancer Res 60: 3807-3812.
7. Winnicka K, Bielawski K, Bielawska A, Surazyński A (2008) Antiproliferative activity of derivatives of ouabain, digoxin and proscillaridin A in human MCF-7 and MDA-MB-231 breast cancer cells. Biol Pharm Bull 31: 1131-1140.
8. Houghton PJ (2010) Everolimus. Clin Cancer Res 16: 1368-1372.
9. Mariniello B, Rosato A, Zuccolotto G, Rubin B, Cicala MV, et al. (2012) Combination of sorafenib and everolimus impacts therapeutically on adrenocortical tumor models. Endocr Relat Cancer 19: 527-539.
10. Lacroix A (2010) Approach to the patient with adrenocortical carcinoma. J Clin Endocrinol Metab 95: 4812-4822.
11. Wang T, Rainey WE (2012) Human adrenocortical carcinoma cell lines. Mol Cell Endocrinol 351: 58-65.
12. Mariniello B, Finco I, Sartorato P, Patalano A, Iacobone M, et al. (2011) Somatostatin receptor expression in adrenocortical tumors and effect of a new somatostatin analog SOM230 on hormone secretion in vitro and in ex vivo adrenal cells. J Endocrinol Invest 34: e131-138.
13. Clark WG, Brater DC, Johnson AR, eds. Goth's Medical Pharmacology. 13th ed. St Louis, Mo: Mosby-Year Book Inc; 1992.
14. Yeh JY, Huang WJ, Kan SF, Wang PS (2001) Inhibitory effects of digitalis on the proliferation of androgen dependent and independent prostate cancer cells. J Urol 166: 1937-1942.
15. Cerquetti L, Sampaoli C, Amendola D, Bucci B, Misiti S, et al. (2010) Mitotane sensitizes adrenocortical cancer cells to ionizing radiations by involvement of the cyclin B1/CDK complex in G2 arrest and mismatch repair enzymes modulation. Int J Oncol 37: 493-501.
16. Wang Z, Zheng M, Li Z, Li R, Jia L, et al. (2009) Cardiac glycosides inhibit p53 synthesis by a mechanism relieved by Src or MAPK inhibition. Cancer Res 69: 6556-6564.
17. Nilubol N, Zhang L, Shen M, Zhang YQ, He M, et al. (2012) Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening. J Transl Med 10: 198.
18. Simpson CD, Mawji IA, Anyiwe K, Williams MA, Wang X, et al. (2009) Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation. Cancer Res 69: 2739-2747.
19. Henery S, George T, Hall B, Basiji D, Ortyn W, et al. (2008) Quantitative image based apoptotic index measurement using multispectral imaging flow cytometry: a comparison with standard photometric methods. Apoptosis 13: 1054-1063.
20. Xu ZW, Wang FM, Gao MJ, Chen XY, Shan NN, et al. (2011) Cardiotonic steroids attenuate ERK phosphorylation and generate cell cycle arrest to block human hepatoma cell growth. J Steroid Biochem Mol Biol 125: 181-191.
21. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, et al. (2001) Essential role of the mitochondrial apoptosisinducing factor in programmed cell death. Nature 410: 549-554.
22. Overbeeke R, Steffens-Nakken H, Vermes I, Reutelingsperger C, Haanen C (1998) Early features of apoptosis detected by four different flow cytometry assays. Apoptosis 3: 115-121.
23. Leist M, Single B, Naumann H, Fava E, Simon B, et al. (1999) Inhibition of mitochondrial ATP generation by nitric oxide switches apoptosis to necrosis. Exp Cell Res 249: 396-403.
24. Foghsgaard L, Wissing D, Mauch D, Lademann U, Bastholm L, et al. (2001) Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol 153: 999-1010.